Average Co-Inventor Count = 2.00
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Wayne State University (11 from 579 patents)
2. Duquesne University of the Holy Spirit (8 from 69 patents)
3. Duquesne University of the Holy Ghost (6 from 70 patents)
14 patents:
1. 11384084 - First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents
2. 11053252 - Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same
3. 10793573 - First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents
4. 10611767 - Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same
5. 10167287 - Substituted pyrimidine compounds and methods of use and manufacture
6. 10000498 - Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same
7. 9650384 - Substituted pyrimidine compounds and methods of use and manufacture
8. 9511069 - Selective proton coupled folate transporter and folate receptor, and GRAFTase inhibitor compounds and methods of using the same
9. 9481678 - Substituted pyrrolo[2,3-D]dipyrimidines for selectively targeting tumor cells with FR-alpha and FR-beta type receptors
10. 9446045 - Methods of using selective chemotherapeutic agents for targeting tumor cells
11. 8952019 - Methods of using selective chemotherapeutic agents for targeting tumor cells
12. 8552014 - Methods of using selective chemotherapeutic agents for targeting tumor cells
13. 8258143 - Methods of using substituted pyrrolo[2,3-d]pyrimidines for targeting tumor cells and treating cancer
14. 8252804 - Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same